Exagen Inc.

Contributing Author

Recent Articles by Exagen Inc.

Jun-23	Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics XGN GlobeNewswire
May-09	Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares XGN GlobeNewswire
May-08	Exagen Inc. Prices Public Offering of Common Stock XGN GlobeNewswire
May-07	Exagen Inc. Announces Proposed Public Offering of Common Stock XGN GlobeNewswire
May-05	Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume XGN GlobeNewswire